Cardiovascular medication :: The total survey results of 2023 by the integrated assestment

The total survey results of 2023 by the integrated assestment in category

Circulatory system / Cardiovascular medication

Integrated, “absolute” ratings is calculated by survey results of 3 respondent groups.

	Consumers (40%)
	Experts (40%)
	Celebrities (20%)

The Favorites of the Year is determined by the Consumers (non-indifferent public), Experts (authoritative specialists of this market industry) and Celebrities Jury (known public figures and celebrities).

In forming of the integrated ratings, the following weight is assumed:

Absolute rank = (average yearly rank of Consumers × 0.4) + (rank of Experts × 0.4) + (rank of Celebrities × 0.2).

1.		Вітрум кардіо / Вітрум кардіо Омега-3 (Такеда)	5

2.	1	Валідол (Лубнифарм)	3.75

2.		Валідол-Дарниця (Darnitsa)	3.75

4.	1	Глоду настоянка (Лубнифарм)	3.13

4.	1	Глоду настоянка (Ternopharm)	3.13

6.	1	Беліса (Vishpha \| Фармацевтична фабрика Vishpha)	1.25

–.	4	Mildronat (Grindex)	0

–.		Validol (Farmak)	0

–.		А-Дістон (Українська Фармацевтична Компанія)	0

–.	4	АТФ-Лонг (Борщагівський ХФЗ)	0

–.	3	АТФ-Лонг (Фаркос)	0

–.		Акард (Polpharma S.A.)	0

–.		Аспаркам (Arterium Corporation)	0

–.		Годасал (PRO.MED.CS Praha a.s.)	0

–.		Екорін (USV Limited)	0

–.		Карвалол-Дарница (Darnitsa)	0

–.		Кардио-гран (Національна гомеопатична спілка)	0

–.		Кардіолін (Українська Фармацевтична Компанія)	0

–.	4	Кардіомагніл (Nycomed)	0

–.		Кардіплант (Schwabe)	0

–.		Кверцетин (Борщагівський ХФЗ)	0

–.		Корвалмент (Київський вітамінний завод)	0

–.		Корвалтаб (Фарма Старт)	0

–.		Кралонін (Heel)	0

–.		Краплі Зеленіна (Фітофарм)	0

–.		Кратал (Борщагівський ХФЗ)	0

–.		Лоспірин (Kusum Pharm)	0

–.		Неокардил (Валартін Фарма)	0

–.		Нітрогліцерин (Технолог)	0

–.		Панангін (Gedeon Richter)	0

–.		Персен Кардіо (Alvogen Ukraine)	0

–.		Пумпан (Perrigo)	0

–.		Ритмокор (Фаркос)	0

–.		Трикардин (Ternopharm)	0

–.		Хомвіокорин-N (Homviora Arzneimittel)	0

–.		Хомвіотензин (Homviora Arzneimittel)	0

The participant which took the 1st place in this rating is by aggregate opinion of all three respondent groups is the best choice in 2023, the absolute recommendation of #1 in the category “Cardiovascular medication”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2023, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media. “Favorite of Success” medal

Participants of the contest (not excluding the leader) can also freely use this information in their news, press releases, reports and other PR-communications. However, it should be understood that the image of the contest awards, such like “Favorite of Success – 2023” medal, which is awarded to the winners at the annual awards ceremony, as well as official winner status &mdashl is the registered Trademarks, and their use requires permission, license.

Leader of this rating has an opportunity to get benefits of the rights and privileges of winner, the “Absolute Favorite”. The winner may be represented in the status of the best choice in the category “Cardiovascular medication”, and receive an award, a gold medal “Favorite of Success – 2023”, on an annual awards ceremony, along with the right to use its image in the advertising and labeling.